- Home
- ROIV vs BROS Comparison
ROIV vs BROS Comparison
Compare ROIV & BROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | BROS |
|---|---|---|
| Founded | 2014 | 1992 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 7.7B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ROIV | BROS |
|---|---|---|
| Price | $28.05 | $47.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 19 |
| Target Price | $27.56 | ★ $77.33 |
| AVG Volume (30 Days) | 4.8M | ★ 5.1M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 88.24 |
| EPS | N/A | ★ 0.64 |
| Revenue | $29,053,000.00 | ★ $1,638,159,000.00 |
| Revenue This Year | N/A | $27.34 |
| Revenue Next Year | $385.85 | $23.20 |
| P/E Ratio | ★ N/A | $75.24 |
| Revenue Growth | N/A | ★ 27.88 |
| 52 Week Low | $8.73 | $46.52 |
| 52 Week High | $30.33 | $77.88 |
Technical Indicators
Market Signals| Indicator | ROIV | BROS |
|---|---|---|
| Relative Strength Index (RSI) | 53.51 | 35.25 |
| Support Level | $26.94 | $46.84 |
| Resistance Level | N/A | $60.44 |
| Average True Range (ATR) | 1.01 | 2.45 |
| MACD | -0.21 | -0.18 |
| Stochastic Oscillator | 32.70 | 8.75 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About BROS Dutch Bros Inc.
Dutch Bros Inc is an operator and franchisor of drive-thru coffee shops that are focused on serving hand-crafted beverages. The company's hand-crafted beverage-focused lineup features hot and cold espresso-based beverages, cold brew coffee products, proprietary energy drinks, tea, lemonade, smoothies and other beverages. The company has two reportable operating segments Company-operated shops and Franchising. It derives maximum revenue from Company operated shops.